Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

Annals of the Rheumatic Diseases
D FargeEBMT/EULAR Registry

Abstract

To analyse the durability of the responses after haematopoietic stem cell transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high transplant related mortality (TRM) improved with experience. This EBMT/EULAR report describes the longer outcome of patients originally described in addition to newly recruited cases. Only patients with SSc, treated by HSCT in European phase I-II studies from 1996 up to 2002, with more than 6 months of follow up were included. Transplant regimens were according to the international consensus statements. Repeated evaluations analysed complete, partial, or non-response and the probability of disease progression and survival after HSCT (Kaplan-Meier). Given as median (range). Among 57 patients aged 40 (9.1-68.7) years the skin scores improved at 6 (n = 37 patients), 12 (n = 30), 24 (n = 19), and 36 (n = 10) months after HSCT (p<0.005). After 22.9 (4.5-81.1) months, partial (n = 32) or complete response (n = 14) was seen in 92% and non-response in 8% (n = 4) of 50 observed cases. 35% of the patients with initial partial (n = 13/32) or complete response (n = 3/14) relapsed within 10 (2.2-48.7) months after HSCT. The TRM was 8.7% (n = 5/57). Deaths related to progression a...Continue Reading

References

Jun 1, 1992·Journal of Autoimmunity·T J WilsonM E Gershwin
Oct 22, 1992·The New England Journal of Medicine·G L LaffelM P Kaye
Apr 11, 1991·Arthritis and Rheumatism·R D AltmanB A Michel
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·S IkeharaY Hamashima
Apr 15, 1995·Lancet·J Giesecke
Feb 1, 1995·The European Respiratory Journal·A U WellsR M du Bois
May 1, 1994·Arthritis and Rheumatism·A AkessonF A Wollheim
Mar 1, 1996·Annals of the Rheumatic Diseases·A Tyndall, A Gratwohl
Nov 5, 1997·Clinical Rheumatology·Z Nagy, L Czirják
Mar 13, 1998·Annals of the Rheumatic Diseases·C P SimeonG Sampol
Oct 3, 1998·Clinical Immunology and Immunopathology·D W van Bekkum
Mar 21, 2000·Bone Marrow Transplantation·E Jantunen, R Myllykangas-Luosujärvi
Nov 18, 2000·Arthritis and Rheumatism·V D Steen, T A Medsger
Nov 30, 2000·Arthritis Research·A Tyndall, A Gratwohl
Aug 11, 2001·Bone Marrow Transplantation·R K BurtP A McSweeney
Nov 20, 2002·British Journal of Haematology·Dominique FargeUNKNOWN Intensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group

❮ Previous
Next ❯

Citations

Nov 22, 2005·Clinical & Developmental Immunology·Gisele Zandman-GoddardYehuda Shoenfeld
Dec 7, 2010·Rheumatology International·Gerald TrangMarie Hudson
Sep 8, 2012·Current Allergy and Asthma Reports·Sheryl MascarenhasStacy P Ardoin
Jan 10, 2009·Clinical Reviews in Allergy & Immunology·Vasiliki Kalliopi K BourniaM Eric Gershwin
Jun 4, 1999·Trends in Microbiology·T F Schulz, P S Moore
Jul 24, 2008·Bone Marrow Transplantation·M RabusinUNKNOWN EBMT Paediatric, Autoimmune Diseases Working Parties
Oct 18, 2011·Bone Marrow Transplantation·J A SnowdenUNKNOWN Paediatric Diseases Working Party (PDWP)
Feb 21, 2008·Nature Clinical Practice. Rheumatology·Nikolay P Nikolov, Steven Z Pavletic
Mar 15, 2005·Bone Marrow Transplantation·A GratwohlUNKNOWN Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Dec 28, 2007·The New England Journal of Medicine·Toshiyuki BohgakiTakao Koike
Jun 12, 2009·Rheumatology·A TyndallU Müller-Ladner
Sep 21, 2013·Current Opinion in Rheumatology·Jacob M van Laar, Keith Sullivan
Oct 6, 2007·Current Opinion in Rheumatology·Alan Tyndall, Daniel E Furst
Sep 4, 2009·Current Opinion in Rheumatology·Niamh P Quillinan, Christopher P Denton
Aug 23, 2011·Current Opinion in Rheumatology·Richard K Burt, Francesca Milanetti
Oct 4, 2008·Current Opinion in Hematology·Riccardo SaccardiAlberto Bosi
Aug 15, 2006·Annals of the Rheumatic Diseases·M Al-mashalehH Englert
Nov 5, 2005·Acta Haematologica·Alan Tyndall, Thomas Daikeler
Mar 21, 2007·Arthritis Research & Therapy·Francesco DazziAlan Tyndall
Sep 15, 2007·Arthritis Research & Therapy·Marco Matucci-CerinicJames R Seibold
Oct 25, 2008·Arthritis Research & Therapy·Thomas Hügle, Jacob M van Laar
May 10, 2007·Drugs·Jacob M van LaarAlan Tyndall
Nov 26, 2010·Immunotherapy·Rebecca Manno, Francesco Boin
Feb 9, 2010·Haematologica·Thomas Hügle, Thomas Daikeler
Nov 5, 2013·Rheumatology·Susanna CappelliMarco Matucci-Cerinic
Jan 1, 2012·ISRN Psychiatry·D D AdamsA Ebringer
Mar 8, 2014·Archivum Immunologiae Et Therapiae Experimentalis·Magdalena WitkowskaPiotr Smolewski
Aug 26, 2014·Clinical Reviews in Allergy & Immunology·Bin LiuPatrick S C Leung
Mar 22, 2013·Current Rheumatology Reports·Kamran Naraghi, Jacob M van Laar
Jul 5, 2006·Zeitschrift für Rheumatologie·F H J van den Hoogen
Jul 22, 2008·Current Rheumatology Reports·Jacob M van Laar, Alan Tyndall
May 26, 2011·Expert Opinion on Biological Therapy·Margit ZeherPeter Szodoray
Nov 5, 2016·Expert Opinion on Orphan Drugs·Fabian A MendozaSergio A Jimenez
Oct 30, 2008·Autoimmunity·Dominique FargeJacob M Laar
Nov 10, 2005·Annals of Medicine·Esa Jantunen, Riitta Luosujärvi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

British Journal of Haematology
D FargeIntensification et Autogreffe dans les Maladies Auto Immunes Resistantes (ISAMAIR) Study Group
Lupus
David JayneEuropean League Against Rheumatism Registry
Bone Marrow Transplantation
A GratwohlAutoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
© 2022 Meta ULC. All rights reserved